FDA-Inspected Site

Amneal Pharmaceuticals Private Limited

2 FDA inspections are on record for Amneal Pharmaceuticals Private Limited in Palli, India.

483· Form 483 issued

Palli, India · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-03-19.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
10 Mar 2025 – 19 Mar 2025Human DrugsWLView 483 →
8 Aug 2022 – 16 Aug 2022Human Drugs483On file

Observations on record

Form 483 observations cited at this site, most recent first.

19 Mar 2025
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Anastasia M Shields, Alan A Rivera

19 Mar 2025
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Anastasia M Shields, Alan A Rivera

19 Mar 2025
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Anastasia M Shields, Alan A Rivera

19 Mar 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Anastasia M Shields, Alan A Rivera

16 Aug 2022
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Matthew B Casale

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Amneal Pharmaceuticals Private Limited's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites